While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

What Is Refractory Multiple Myeloma? Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell, which helps your immune system fight infections. Refractory means ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Multiple myeloma is a rare cancer that originates in white blood cells (plasma cells) that produce antibodies.

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...